Top of this page
Skip navigation, go straight to the content

Newsroom Press Releases

Search Press releases


UCB and Amgen Resubmit Biologics Licence Application (BLA) for EVENITYTM (Romosozumab) to the U.S. FDA12 Jul 2018

UCB and Amgen Resubmit Biologics Licence Application (BLA) for EVENITYTM …

Read more
Transparency notification 12 Jul 2018

Transparency notification 

Read more
Transparency notifications BlackRock, Inc.06 Jul 2018

Transparency notifications BlackRock, Inc.

Read more
UCB announces approval of NEUPRO® in China to treat Parkinson’s Disease02 Jul 2018

UCB announces approval of NEUPRO® in China to treat Parkinson …

Read more
New UCB Research Showcases Value of CIMZIA® (certolizumab pegol) in Psoriasis and Highlights Unique Experiences and Real World Evidence for Key Patient Populations 27 Jun 2018

New UCB Research Showcases Value of CIMZIA® (certolizumab pegol) in …

Read more
New Study Presented at the Annual European Congress of Rheumatology (EULAR 2018) Reveals Insights About Women with Chronic Rheumatic Diseases During Their Pregnancy Journey 14 Jun 2018

New Study Presented at the Annual European Congress of Rheumatology …

Read more


Stay up-to-date on the latest news and information from UCB